Skip to main content

David Rodriguez Luna

Institutions of which they are part

Main researcher
Stroke research
Vall Hebron Institut de Recerca

David Rodriguez Luna

Institutions of which they are part

Main researcher
Stroke research
Vall Hebron Institut de Recerca

Projects

VALIDATE: Validation of a Trustworthy AI-based Clinical Decision Support System for Improving Patient Outcome in Acute Stroke Treatment

IP: Marta Aurora Rubiera Del Fueyo
Collaborators: Maria Victoria Sala Sanz de Madrid, Cristina Guirao Martinez, Claudia Meza Burgos, Federica Rizzo, Ester Sanchez Gavilan, David Rodriguez Luna, Renato Simonetti
Funding agency: EUROPEAN COMMISSION
Funding: 567950
Reference: VALIDATE_HE-HLTH-DISEASE21
Duration: 01/05/2022 - 30/04/2026

Empower-ICH: eficacia de la implementación de un sistema de telemonitorización de la presión arterial ambulatoria en pacientes con hemorragia intracerebral

IP: David Rodriguez Luna
Collaborators: Noelia Rodríguez Villatoro, Olalla Pancorbo Rosal
Funding agency: Instituto de Salud Carlos III
Funding: 38720
Reference: PI20/00834
Duration: 01/01/2021 - 30/06/2025

Estudio de la implicación de la distribución de la apolipoproteína J (ApoJ/Clusterin) en lipoproteínas circulantes en la Angiopatía Amiloide Cerebral

IP: Maria Mar Hernandez Guillamon
Collaborators: Anna Bonaterra Pastra, Guillem Colell Dinares, David Rodriguez Luna
Funding agency: Instituto de Salud Carlos III
Funding: 110715
Reference: PI17/00275
Duration: 01/01/2018 - 31/12/2020

Impact of time to achieve blood pressure control on hematoma expansion in patients with acute intracerebral hemorrhage

IP: David Rodriguez Luna
Collaborators: Maria Mar Hernandez Guillamon, Mª Ángeles Muchada López
Funding agency: Fundació La Marató de TV3
Funding: 177052.88
Reference: 20173030
Duration: 01/01/2018 - 31/01/2022

Related news

The Consortium will create a platform to facilitate a personalised management for stroke patients, enabling a more efficient personalized monitoring and patient follow up.

Funding is key to bringing the neuroprotective drug ApTOLL to market and providing a new therapeutic option for the patients.

The award is a recognition for his significant contribution to the development of research in multiple sclerosis within the Catalan Institute of Health.

Related professionals

Estrella Caballero Requero

Estrella Caballero Requero

Microbiology
Read more
Brigidi , Serena

Brigidi , Serena

Main researcher
Maternal and Fetal Medicine
Read more
Martincic , Markus

Martincic , Markus

Tècnic/a Grau Superior
International Projects Unit
Competitive Projects Area
Read more
Lluis Armadans Gil

Lluis Armadans Gil

Main researcher
Epidemiology and Public Health
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.